34248311|t|Genetic Control of Human Infection with SARS-CoV-2.
34248311|a|In 2019, the SARS-CoV-2 beta-coronavirus, which caused a pandemic of severe acute respiratory viral infection COVID-19 (from COronaVIrus Disease 2019), was first detected. The susceptibility to SARS-CoV-2 and the nature of the course of the COVID-19 clinical picture are determined by many factors, including genetic characteristics of both the pathogen and the human. The SARS-CoV-2 genome has a similarity to the genomes of other coronaviruses, which are pathogenic for humans and cause a severe course of infection: 79% to the SARS-CoV genome and 50% to the MERS-CoV genome. The most significant differences between SARS-CoV-2 and other coronaviruses are recorded in the structure of the gene of the S protein, a key protein responsible for the virus binding to the receptor of the host organism cells. In particular, substitutions in the S protein of SARS-CoV-2, leading to the formation of the furin cleavage site that is absent in other SARS-like coronaviruses, were identified, which may explain the high pathogenicity of SARS-CoV-2. In humans, the genes that are significant for the initial stages of infection include ACE2, ANPEP, DPP4 (encode receptors for coronavirus binding); TMPRSS2, FURIN, TMPRSS11D, CTSL, CTSB (encode proteases involved in the entry of the coronavirus into the cell); DDX1 (the gene of ATP-dependent RNA helicase DDX1, which promotes replication of coronaviruses); and IFITM1, IFITM2, and IFITM3 (encode interferon-induced transmembrane proteins with an antiviral effect). These genes are expressed in many tissues (including those susceptible to the effects of SARS-CoV-2); rare and frequent variants that affect the structure of the encoded protein and its properties and expression level are described in them. A number of common genetic variants with proven functional significance are characterized by the variability in the allele frequency in the world's populations, which can determine interpopulation differences in the prevalence of COVID-19 and in the clinical features of the course of this pathology. The expression level of genes that are important for the formation of the susceptibility to SARS-CoV-2 is affected by epigenetic modifications, comorbidities at the time of infection, taking medications, and bad habits.
34248311	19	34	Human Infection	Species	
34248311	40	50	SARS-CoV-2	Disease	MESH:D000086382
34248311	65	92	SARS-CoV-2 beta-coronavirus	Species	
34248311	121	127	severe	Disease	MESH:D045169
34248311	134	170	respiratory viral infection COVID-19	Disease	MESH:D000086382
34248311	177	201	COronaVIrus Disease 2019	Disease	MESH:D000086382
34248311	246	256	SARS-CoV-2	Species	2697049
34248311	293	301	COVID-19	Disease	MESH:D000086382
34248311	414	419	human	Species	9606
34248311	425	435	SARS-CoV-2	Species	2697049
34248311	484	497	coronaviruses	Species	694013
34248311	524	530	humans	Species	9606
34248311	543	549	severe	Disease	MESH:D045169
34248311	560	569	infection	Disease	MESH:D007239
34248311	582	590	SARS-CoV	Species	694009
34248311	613	621	MERS-CoV	Disease	MESH:D018352
34248311	671	681	SARS-CoV-2	Species	2697049
34248311	692	705	coronaviruses	Species	694013
34248311	907	917	SARS-CoV-2	Species	2697049
34248311	951	956	furin	Gene	5045
34248311	995	1018	SARS-like coronaviruses	Disease	MESH:D045169
34248311	1081	1091	SARS-CoV-2	Disease	MESH:D000086382
34248311	1096	1102	humans	Species	9606
34248311	1161	1170	infection	Disease	MESH:D007239
34248311	1179	1183	ACE2	Gene	59272
34248311	1185	1190	ANPEP	Gene	290
34248311	1192	1196	DPP4	Gene	1803
34248311	1219	1230	coronavirus	Species	694013
34248311	1241	1248	TMPRSS2	Gene	7113
34248311	1250	1255	FURIN	Gene	5045
34248311	1257	1266	TMPRSS11D	Gene	9407
34248311	1268	1272	CTSL	Gene	1514
34248311	1274	1278	CTSB	Gene	1508
34248311	1326	1337	coronavirus	Species	694013
34248311	1354	1358	DDX1	Gene	1653
34248311	1399	1403	DDX1	Gene	1653
34248311	1435	1448	coronaviruses	Species	694013
34248311	1455	1461	IFITM1	Gene	8519
34248311	1463	1469	IFITM2	Gene	10581
34248311	1475	1481	IFITM3	Gene	10410
34248311	1648	1658	SARS-CoV-2	Species	2697049
34248311	2030	2038	COVID-19	Disease	MESH:D000086382
34248311	2193	2203	SARS-CoV-2	Species	2697049
34248311	2274	2283	infection	Disease	MESH:D007239
34248311	Association	MESH:D007239	5045
34248311	Association	MESH:D007239	1508
34248311	Association	MESH:D007239	59272
34248311	Association	MESH:D007239	9407
34248311	Association	MESH:D007239	290
34248311	Association	MESH:D007239	1803
34248311	Association	MESH:D007239	1514
34248311	Association	MESH:D007239	7113

